A-234 (nerve agent)

From WikiMD's WELLNESSPEDIA

A-234 (nerve agent)

Chemical compound

A-234 is a nerve agent of the Novichok agent family, developed in the Soviet Union and Russia from the 1970s to the 1990s. It is one of the most potent nerve agents known, with a mechanism of action similar to other organophosphate nerve agents such as sarin and VX.

Chemical structure and properties[edit]

A-234 is an organophosphate compound, characterized by the presence of a phosphorus atom bonded to an oxygen atom and a fluorine atom, as well as a carbon-containing group. The chemical structure of A-234 is similar to other Novichok agents, which are designed to be more toxic and harder to detect than earlier nerve agents.

Chemical structure of A-234 as described by Mirzayanov
Alternative chemical structure of A-234 as described by Hoenig

Mechanism of action[edit]

A-234, like other nerve agents, inhibits the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine in the synaptic cleft. This inhibition leads to an accumulation of acetylcholine, resulting in continuous stimulation of muscles, glands, and central nervous system structures. The overstimulation causes symptoms such as muscle twitching, paralysis, respiratory failure, and potentially death.

Symptoms of exposure[edit]

Exposure to A-234 can cause a range of symptoms, depending on the dose and route of exposure. Symptoms may include:

Treatment[edit]

The treatment for A-234 poisoning is similar to that for other nerve agents and includes the administration of atropine, an anticholinergic drug that blocks the effects of acetylcholine, and pralidoxime, which reactivates acetylcholinesterase. Benzodiazepines may also be used to control seizures.

History and development[edit]

The development of A-234 and other Novichok agents was part of a secret Soviet program aimed at creating more effective chemical weapons that could evade international detection and control measures. The existence of these agents was revealed by Vil Mirzayanov, a former Soviet scientist, in the 1990s.

Related pages[edit]

Gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.